Cargando…

Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer

Cancer has been considered as temporal and spatial aberrations of normal development in tissues. Similarities between mammary embryonic development and cell transformation suggest that the underlying processes required for mammary gland development are also those perturbed during various stages of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rangel, Maria Cristina, Bertolette, Daniel, Castro, Nadia P., Klauzinska, Malgorzata, Cuttitta, Frank, Salomon, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819564/ https://www.ncbi.nlm.nih.gov/pubmed/26968398 http://dx.doi.org/10.1007/s10549-016-3746-7

Ejemplares similares

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

Recombinant R-spondin2 and Wnt3a Up- and Down-Regulate Novel Target Genes in C57MG Mouse Mammary Epithelial Cells
por: Baljinnyam, Bolormaa, et al.
Publicado: (2012)

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, María V, et al.
Publicado: (2020)

Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers
por: Lee, Hyun Ju, et al.
Publicado: (2021)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Embryonic Stem Cells Are Redirected to Non-Tumorigenic Epithelial Cell Fate by Interaction with the Mammary Microenvironment
por: Boulanger, Corinne A., et al.
Publicado: (2013)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013)

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020)

Dermal fibroblasts and triple-negative mammary epithelial cancer cells differentially stiffen their local matrix
por: Jagiełło, Alicja, et al.
Publicado: (2020)

Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy
por: Fang, Changge, et al.
Publicado: (2013)

Developmental Expression of Claudins in the Mammary Gland
por: Baumgartner, Heidi K., et al.
Publicado: (2017)

Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
por: Amirkhani Namagerdi, Asadoor, et al.
Publicado: (2020)

Developmental regulation of mammary-derived growth inhibitor expression in bovine mammary tissue
Publicado: (1990)

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
por: Mahfoudh, Wijden, et al.
Publicado: (2019)

Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells
por: Trichopoulos, Dimitrios, et al.
Publicado: (2005)

Contribution to the Etiology of Neuralgia
Publicado: (1888)

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
por: Caliari, Diego, et al.
Publicado: (2014)

Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice
por: Luo, Xu-Liang, et al.
Publicado: (2020)

Tracking the Progression of Triple Negative Mammary Tumors over Time by Chemometric Analysis of Urinary Volatile Organic Compounds
por: Woollam, Mark, et al.
Publicado: (2021)

Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy
por: Lei, Josh Haipeng, et al.
Publicado: (2021)

CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer
por: Zheng, Qianqian, et al.
Publicado: (2020)

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer
por: Bambhroliya, Arvind, et al.
Publicado: (2018)

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer
por: Colavito, Sierra A., et al.
Publicado: (2019)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Crosstalk between the Smad and the Mitogen-Activated Protein Kinase Pathways is Essential for Erythroid Differentiation of Erythroleukemia Cells Induced by TGF-β, Activin, Hydroxyurea and Butyrate
por: Akel, Salem, et al.
Publicado: (2013)

A Contribution to the Etiology of Cholera
por: Hankin, E. H.
Publicado: (1895)

A Contribution to the Etiology of Cholera
por: Haffkine, W. M., et al.
Publicado: (1895)

A Contribution to the Etiology of Cholera
por: Hehir, P.
Publicado: (1895)

A Contribution to the Etiology of Neuralgia
por: Whitwell, James R.
Publicado: (1887)

Contribution to the Etiology of Lameness in Colts
por: Caspar, M.
Publicado: (1898)

Mammary stem cells: angels or demons in mammary gland?
por: Chen, Xueman, et al.
Publicado: (2017)

Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer
por: Banda, Malathi, et al.
Publicado: (2014)

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
por: Barton, Maria, et al.
Publicado: (2019)

Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland
por: Kenney, Nicholas J, et al.
Publicado: (2001)

Epidemiology and etiology of infantile developmental and epileptic encephalopathies in Tasmania
por: Ware, Tyson L., et al.
Publicado: (2019)

Developmental Dysplasia of the Hip (DDH): Etiology, Diagnosis, and Management
por: Bakarman, Khaled, et al.
Publicado: (2023)

Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
por: Ho, Bing-Ying, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e0ugc6t0g3ii9vjde3cdbaa7kc